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Light-driven water oxidation and plastoquinone reduction is
catalyzed by photosystem II (PSII) embedded in the thylakoid mem-
brane of higher plants, algae, and cyanobacteria [1–3]. An essential
part of PSII is cytochrome b559 (cyt b559), which is a heme-bridged
protein consisting of α and β subunits [4–6]. It has been shown that
the heme iron is coordinated by two histidine residues, His22 of the α
and His17 of the β subunit of the heterodimer [7–9]. Crystal structures
of PSII from thermophilic cyanobatecteria Thermosynechococcus
elongatus and Thermosynechococcus vulcanus revealed that the heme
is located near the stromal side of the membrane and is oriented
perpendicular to the plane of the membrane [10–13]. The most recent
crystal structure provides a more detailed map of cyt b559 in relation
to the third quinone-binding QC site and binding of plastoquinone
molecule to the QC site [14].Cytochrome b559 can exist in several forms that differ in the redox
potential properties of the heme iron: the high-potential (HP) form
(midpoint redox potential Em∼+400 mV), the intermediate-poten-
tial (IP) form (Em∼+200 mV) and the low-potential (LP) form
(Em∼+50 mV) [15–18]. Several hypotheses have been proposed to
explain the existence of different redox potential forms of cyt b559: 1)
orientation of the two histidine imidazole rings [7], 2) variation in the
nature of the heme coordination [17], 3) different hydrophobicity of
the heme environment [19], and 4) protonation state of the histidine
imidazole ring [16,18,20]. It has been proposed that the protein
environment around the heme iron in the HP form of cyt b559 is
supposed to be more hydrophobic with a lower dielectric constant,
whereas it is less hydrophobic and more open to the polar medium in
the LP form of cyt b559 [18,19]. It has been suggested previously that
binding of the PQ to the QC site is essential for the establishment of the
HP form of cyt b559 [21,22]. The structural details of the QC site
provided by recent crystal structure [14] show that the isoprenoid
chain of a PQ molecule bound at the QC site is located close to the
heme of cyt b559. This ﬁnding strongly supports the hypothesis that
the maintenance of the hydrophobic environment of the heme is
necessary for the stability of the HP form of cyt b559. The protonation
of the imidazole group of histidine residues and the formation of
hydrogen bonds with the polypeptide backbone are prerequisites for
the conversion of cyt b559 into its HP form [18]. It has been proposed
earlier that in the HP form of cyt b559, hydrogen bonds are present
between the imidazole NH of the both histidine residues and carbonyl
groups of the peptide backbone. However, in the LP form of cyt b559
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hydrogen bond was proposed to stabilize the HP form of cyt b559 by
maintaining hydrophobic environment around the heme iron [18].
In active PSII membranes, cyt b559 is present in the reduced HP
form (70%), whereas the remaining 30% of cyt b559 is in the oxidized
LP form [16–18]. Several harsh treatments, which destabilize the
integrity of PSII, are known to convert cyt b559 from the HP to the LP
form [21–25]. One such treatment is the incubation of PSII mem-
branes with Tris, which results in the dissociation of the water-
splitting manganese complex on the PSII electron donor side. In Tris-
treated PSII membranes, the reduced HP form of cyt b559 is absent and
cyt b559 is present only in the oxidized LP form [26–29]. However,
illumination or removal of molecular oxygen from Tris-treated PSII
membranes was shown to convert the LP form of cyt b559 back into
the HP form typical for untreated PSII [26–31]. Mizusawa et al.
demonstrated that either continuous or pulsed light restored the HP
form of cyt b559 during photoactivation [26,30,31]. Reversible
transition between the LP and the HP form of cyt b559 was shown
under transition from aerobic to anaerobic or oxidizing to reducing
conditions in Tris-treated PSII membranes [28]. Recently, detailed
study on the redox changes of cyt b559 from the IP to the HP form in
PSII membranes with a different degree of disintegration of PSII
electron donor side was presented [29]. As far as we know, the effect
of pH on redox changes of cyt b559 induced by light or removal of
molecular oxygen in Tris-treated PSII membranes has not been
studied yet.
In this work, the effect of pH and histidine modiﬁcation on the
light- and oxygen-dependent redox changes of cyt b559 was studied in
Tris-treated PSII membranes. We have demonstrated that the light-
induced conversion of cyt b559 from the IP to the HP form is
suppressed by high pH and histidine modiﬁcation, whereas it was
independent of pH and histidine modiﬁcation, when induced by
removal of molecular oxygen. Thus, based on the redox state of the
heme iron and on the difference in pH dependence of these
conversions, it has been suggested that the mechanism of conversion
of cyt b559 from the IP to the HP form by illumination and by removal
of molecular oxygen could be entirely different.2. Materials and methods
2.1. PSII membrane preparation
PSII membranes were prepared from dark-adapted spinach leaves
using the method of Berthold et al. [32] with the modiﬁcations
described in Ford and Evans [33]. The isolated PSII membranes were
stored at−80 °C in suspending medium containing 400 mM sucrose,
10 mM NaCl, 5 mM CaCl2 and 40 mM Mes–NaOH (pH 6.5) until
further use. Tris-treated PSII membranes were prepared by incubation
of PSII membranes (1 mg Chl ml−1) in a buffer containing 0.8 M Tris–
HCl (pH 8) for 30 min at 4 °C, in the darkness under continuous gentle
stirring. After the treatment, PSII membranes were washed twice in
the suspendingmedium. All the measurements were performed using
the same suspending medium (pH 6.5), unless stated otherwise.2.2. Anaerobic conditions
Anaerobic conditionswere established bymixing50 U ml−1 glucose
oxidase (EC 1.1.3.4, from Aspergillus niger) (Fluka), 500 U ml−1 catalase
(EC 1.11.1.6, from Bovine liver) (Sigma) and 5 mM glucose with the
suspending medium (pH 6.5). During addition of the oxygen trap, air
was removed from the upper part of the cuvette by a gentle stream of
argon and the cuvette was sealed with the help of a 1 cm thick rubber
cap andparafﬁnwax. Tomaintain anaerobic conditions, reducingagents
were added in the sealed cuvette with the help of a micro-syringe.2.3. Histidine modiﬁcation treatment
Chemical modiﬁcation of the imidazole rings of the histidine
residues was performed using diethylpyrocarbonate (DEPC) (Aldrich)
according to the method of Hegde et al. [34] with modiﬁcation
described in Roncel et al. [18]. Tris-treated PSII membranes
(50 µg Chl ml−1) were treated with 5 mM DEPC for 15 min at 25 °C
under stirring. The reaction was terminated by the addition of a large
volume of histidine solution to PSII membranes to the ﬁnal
concentration of 20 mM and incubated for 1 min in the dark. After
incubation, PSII membranes were washed twice and re-suspended in
50 mM Mes (pH 5.5). Selective modiﬁcation of the imidazole groups
using histidine-modifying reagent DEPC caused carbethoxylation of
imidazole rings. Diethylpyrocarbonate binds to the imidazole group as
a covalent probe of protein surface structure and prevents its
protonation by protons in the medium.
2.4. Optical measurements
Redox properties of cyt b559 were monitored by following the
absorbance changesusingOlis RSM1000spectrometer (Olis Inc., Bogart,
Georgia, USA) as described [26,27]. Tris-treated PSII membranes
(250 μg Chl ml−1) were treated with 50 µM potassium ferricyanide
(reference cuvette) and 8 mM hydroquinone, 5 mM sodium ascorbate
or sodiumdithionite (test cuvette) in a 3 ml quartz cuvette (path length
1 cm) at 20 °C. Addition of each reductant was followed by dark
adaptation for 5 min under continuous slow stirring inside the
spectrophotometer using a tiny bar magnet, unless stated otherwise.
After switching off the stirring, absorption spectra were recorded from
530 nm to 580 nm. The spectral slit width, the total bandpass and the
scan speedwere 0.12 mm, 0.5 nm and 50 nmper min, respectively. The
amount of cyt b559 was calculated on the basis of its molar extinction
coefﬁcient (17.5 mM−1 cm−1). The observed ratio of cyt b559:Chl was
1:230. The amount of cyt b559 in different forms was determined from
difference spectra observed in the presence of particular oxidant and
reductant (average from 5 measurements). Total HP form was
determined from a difference spectrum of hydroquinone-reduced
minus ferricyanide-oxidized cyt b559. The IP form was determined by
difference spectra of ascorbate-reduced minus hydroquinone-reduced
cyt b559. The LP form was obtained by dithionite-reduced minus
ascorbate-reduced spectrum. Previously, dithionite-reducible form has
been considered as very low-potential form (VLP); however, the
nomenclature used in this study to describe different forms of cyt b559
is according to the recently established facts [28,29], which is based on
their redox potential range obtained from potentiometric titration. The
light-induced formation of the HP form of cyt b559 was monitored as a
difference between the dark-adapted ferricyanide-oxidized spectrum
and the absorption spectrummeasured after 100 s of illumination. Illu-
mination was performed with continuous white light (1000 μmol pho-
tons m−2 s−1) using halogen cold light source (Schott KL 1500, Schott
AG, Mainz, Germany) by 90° rotating the cuvette at each 15 s intervals.
2.5. Potentiometric measurements
Potentiometric redox titrations of Tris-treated PSII membranes
(250 μg Chl ml−1) were performed at room temperature as described
previously [18], using potentiometer Oxi 340i (WTW GmbH,
Weilheim, Germany) equipped with the Pt–Ag/AgCl redox micro-
electrode (Pt 5900 A, Schott Instruments GmbH, Mainz, Germany).
Potentiometric measurements were performed simultaneously with
measurements of absorbance changes at 559 nm. Redox microelec-
trode (5 mm diameter) was placed inside the test cuvette of the
spectrophotometer in such a way that it did not affect the light path.
For anaerobic titration, molecular oxygen was removed from the
cuvette using glucose/glucose oxidase/catalase system as described
in the previous section. Prior to the reductive titration, PSII
Fig. 1. (A), Redox changes of cyt b559 measured in Tris-treated PSII membranes in the
dark (left column), after illumination for 100 s (middle column) and after removal of
molecular oxygen (right column). In the middle column, sample was illuminated for
100 s with continuous white light (1000 µmol photons m−2 s−1). In the right column,
molecular oxygen was removed by using oxygen trap (5 mM glucose, 50 U ml−1,
glucose oxidase, 500 U ml−1 catalase). The LP form represents dithionite-reduced
minus ascorbate-reduced difference spectra and the IP form represents ascorbate-
reduced minus hydroquinone-reduced difference spectra. The HP form represents
hydroquinone-reduced minus ferricyanide-oxidized difference spectra (the left and the
right column) and light minus ferricyanide-oxidized difference spectra (middle
column). The spectra were smoothed using ﬁve points averaging of experimental
data by the Origin v4.1 software. (B), Reductive potentiometric titrations of cyt b559 in
Tris-treated PSII membranes measured under anaerobic conditions. The inset shows
reductive potentiometric titrations of cyt b559 in Tris-treated PSII membranes measured
under aerobic conditions in the dark (□) and after illumination with white light
(1000 μmol photons m−2 s−1) for 100 s (■). The symbols show data points of the
titration curve, whereas solid lines represent the best ﬁts of the experimental data to
Nernst equation in accordance with the one-electron process (n=1) for one or three
redox components. Reductive potentiometric titrations were repeated three times with
the similar proﬁle of the redox titration curve. In all themeasurements, Tris-treated PSII
membranes (250 μg Chl ml−1) suspended in medium containing 400 mM sucrose,
10 mM NaCl, 5 mM CaCl2 and 40 mM Mes–NaOH (pH 6.5) were used.
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+430 mV, pH 7). Reductive titrations were carried out in the
presence of the following redox mediators: 20 µM p-benzoquinone
(Em=+280 mV, pH 7), 20 µM 2,5-dimethyl-p-benzoquinone (Em=
+180 mV, pH 7), 20 µM N-methylphenazoniummethosulfate (Em=
+80 mV, pH 7), 20 µM sodium ascorbate (Em=+60 mV, pH 7), and
20 µM sodium dithionite (Em=−660 mV, pH 7). Stirring was
‘switched on’ before the addition of the mediators and ‘switched off’
before starting the measurements. The dilution resulting from the
titration was compensated by the addition of buffer solution in the
reference cuvette. Midpoint redox potential and fraction of reduced
cyt b559 were determined by ﬁtting of the redox titration curve to
Nernst equation in accordance with one-electron process (n=1) for
one or three redox components.
3. Results
3.1. Light-induced conversion of cyt b559 from the IP to the HP form
In this study, Tris-treated PSII membranes deprived of water-
splitting manganese complex and 17, 23, 33 kDa extrinsic polypep-
tides were used to study the effect of illumination on cyt b559. Redox
properties of cyt b559 were monitored by measuring the absorbance
changes at 559 nm after oxidation of cyt b559 with potassium
ferricyanide and reduction by hydroquinone (the HP form), sodium
ascorbate (the IP form) and sodium dithionite (the LP form). In the
dark, Tris-treated PSII membranes contained the dithionite-reducible
LP form and the ascorbate-reducible IP form of cyt b559, whereas the
hydroquinone-reducible HP form of cyt b559 was absent (Fig. 1A, left
column). Upon illumination of Tris-treated PSII membranes for 100 s,
the reduced HP form (HPFe2+) of cyt b559 was formed, whereas the
ascorbate-reducible IP form of cyt b559 was decreased (Fig. 1A, middle
column). Potentiometric redox titration of illuminated Tris-treated
PSII membranes performed under aerobic conditions conﬁrmed the
appearance of the HP form of cyt b559 with Em∼+310 mV (Fig 1B,
inset, closed square). Due to the interference of molecular oxygen
below the ambient potential of +100 mV, the potentiometric redox
titration under aerobic conditions was performed up to the ambient
potential of +100 mV. Thus, the IP and the LP forms could not be
detected under these conditions. Potentiometric redox titration of
Tris-treated PSII membranes measured under aerobic conditions in
the dark did not show any redox potential form at ambient potential
above +100 mV (Fig. 1B, inset, open square).
3.2. Conversion of cyt b559 from the IP to the HP form under anaerobic
conditions
Furthermore, the effect of molecular oxygen on redox properties of
cyt b559 was studied in Tris-treated PSII membranes. The removal of
molecular oxygen using glucose/glucose oxidase/catalase system
lowered the content of the ascorbate-reducible IP form of cyt b559,
whereas the hydroquinone-reducible HP form of cyt b559 appeared
(Fig. 1, right column). Therefore, it can be concluded that the removal
of molecular oxygen resulted in partial conversion of cyt b559 from the
IP to the oxidized HP form (HPFe3+). Potentiometric redox titration of
Tris-treated PSII membranes under anaerobic conditions showed the
existence of three redox forms with midpoint redox potential of
+306 mV, +140 mV and−42 mV (Fig. 1B).
To quantify the effect of molecular oxygen on the conversion of cyt
b559 from the IP to the HP form, the formation of the HP form of cyt
b559 was studied under different concentrations of molecular oxygen.
The concentration of molecular oxygen was regulated in the solution
by changing the concentration of glucose substrate in glucose/glucose
oxidase/catalase system. The conversion of cyt b559 from the IP to the
HP form was triggered by lowering the concentration of molecular
oxygen by approx. 20% (down to ∼220 µM) and the completeconversion was achieved by about 40% drop in oxygen concentration
(down to ∼168 µM) (Fig. 2).
Fig. 1A shows that neither illumination nor removal of molecular
oxygen affected the content of the dithionite-reducible LP form of cyt
b559 in Tris-treated PSII membranes. Therefore, further experiments
have been designed to study only two forms of cyt b559 i.e. the light-
or hydroquinone-reducible HP form and the ascorbate-reducible IP
form.
Fig. 2. Effect of oxygen concentration on the formation of the HP form of cyt b559 in Tris-
treated PSII membranes. Concentration of molecular oxygen was measured with a
Clark-type electrode (Hansatech, UK) assuming a saturation concentration of dissolved
oxygen of 280 nmol ml−1 in salt containing buffer at 23 °C. The intensity of the
absorption signal was calculated as the height of the peak at 559 nm from a reference
line connecting the lowest points near 545 and 575 nm. Each data point represents the
mean value of at least three measurements. Medium composition and pH were as
described in Fig. 1.
Fig. 3. Effect of pH on the formation of the HP form of cyt b559 measured in Tris-treated
PSII membranes after (A) illumination for 100 s and (B) removal of molecular oxygen.
Data points represent the height of the absorption maximum at 559 nm obtained from
the light minus ferricyanide-oxidized difference spectra (A) and the hydroquinone-
reducedminus ferricyanide-oxidized difference spectra (B). In B, to study the formation
of the HP form of cyt b559 molecular oxygen was removed after adjusting the pH (open
circles), whereas to explore the stability of the HP form of cyt b559 pHwas adjusted after
the removal of molecular oxygen (closed circles). The measurements were performed
using suspending medium containing 400 mM sucrose, 10 mM NaCl, 5 mM CaCl2 and
40 mM Mes–NaOH (pH 5.5–6.5) or 40 mM Hepes–NaOH buffer (pH 7–8), or 40 mM
Tricine (pH 8.5), or 40 mM Capso (pH 9–10). Other experimental conditions were the
same as described in Fig. 1.
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cyt b559
Fig. 3 shows the effect of high pH on light- and oxygen-dependent
redox changes of cyt b559 in Tris-treated PSII membranes. Above pH 8,
light-induced conversion of cyt b559 from the IP to the HP form was
completely suppressed (Fig. 3A). A sigmoid curve with pKa value of
∼7.4 was obtained by ﬁtting of the experimental data. This
observation indicates that light-induced conversion of cyt b559 from
the IP to the HP form is dependent on the concentration of protons in
the polar phase.
Interestingly, upon removal of molecular oxygen, the IP form of cyt
b559 was readily converted into the HP form of cyt b559 even at high pH
(up to pH 10) (Fig 3B, open circles). This indicates that the conversion
of the IP to theHP formof cyt b559 under anaerobic conditions is largely
independent on pH. To study the stability of the HP form at high pH,
ﬁrst molecular oxygen was removed using oxygen trap to form the HP
form of cyt b559 and then pH was changed. Fig. 3B (closed circles)
shows that the stability of the HP form of cyt b559 is unaffected at high
pH. These results indicate that under anaerobic conditions the
conversion of the IP to the HP form of cyt b559 as well as the stability
of the HP form of cyt b559 is independent on pH, i.e. on proton con-
centration in the polar phase.
3.4. Effect of histidine modiﬁcation on light- and oxygen-dependent
redox changes of cyt b559
To ﬁnd out whether the protonation of histidine plays any role in
light- and oxygen-dependent redox changes of cyt b559, histidine-
modiﬁed PSII membranes were used. Histidine-modifying reagent
DEPC is known to covalently bind to nitrogen (N1) of the histidine
residue, replacing thus the hydrogen normally present on the
imidazole ring [34,35]. In histidine-modiﬁed Tris-treated PSII mem-
branes, cyt b559 was present in the ascorbate-reducible IP form,
whereas the hydroquinone-reducible HP form was completely absent
(Fig. 4, left column). Upon illumination of histidine-modiﬁed PSIImembranes for 100 s, no HP form of cyt b559 was detected and the
amount of the IP form of cyt b559 was not changed (Fig. 4, middle
column). The ﬁnding that the light-induced conversion of the IP to the
HP form of cyt b559 is completely suppressed in histidine-modiﬁed
PSII membranes indicates that the protonation of the histidine residue
is essential for this conversion. Surprisingly, the modiﬁcation of
histidine did not affect the conversion of the IP to the HP form of cyt
b559 induced by anaerobic conditions. The removal of molecular
oxygen in histidine-modiﬁed Tris-treated PSII membranes led to the
formation of the hydroquinone-reducible HP form at the expense of
the ascorbate-reducible IP form (Fig. 4, right column).
Fig. 4. Effect of histidine modiﬁcation on redox changes of cyt b559 measured in Tris-
treated PSII membranes in the dark (left column), after illumination for 100 s (middle
column) and after removal of molecular oxygen (right column). Chemical modiﬁcation
of the imidazole ring of the histidine residue was performed using diethylpyrocarbo-
nate as described in Materials and methods. The suspending medium and other
experimental conditions were as described in Fig. 1.
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In agreement with previous studies [26–31], we have demonstrat-
ed that illumination and removal of molecular oxygen in Tris-treated
PSII membranes resulted in the conversion of cyt b559 from the IP to
the HP form. However, for the ﬁrst time we have studied how this
conversion is affected by pH and by the protonation of histidine res-
idues, which coordinate the heme iron of cyt b559. The light-induced
conversion of cyt b559 from the IP to the HP form was found to be pH-
dependent, whereas the conversion induced by the removal of
molecular oxygen was unaffected by pH. Based on these observations,
it is proposed that pH of the reactionmedium is a limiting factor for the
conversion of cyt b559 from the IP to the HP form during illumination
but not under anaerobic environment.
4.1. Light-induced conversion of cyt b559 from the IP to the HP form
Illumination of Tris-treated PSII membranes caused the conversion
of the IP to the HP form of cyt b559 and reduction of the heme iron
(Eq. (1)).
IP cyt b559ðFe3+Þ→
light HP cyt b559ðFe2+Þ ðpH  dependentÞ: ð1Þ
Recently, we have proposed a detailed mechanism of light-
induced conversion of cyt b559 from the IP to the HP form in Tris-
treated PSII membranes [27]. It has been demonstrated that the light-
induced conversion of the IP to the HP form of cyt b559 is mediated by
superoxide anion radical (O2•−) generated by PSII. It has been
proposed that the interaction of O2•− with ferric heme iron of the IP
form induced the conversion of cyt b559 into ferrous heme iron of the
HP form and the release of molecular oxygen. Our ﬁnding that the
light-induced conversion of cyt b559 from the IP to the HP form is
completely suppressed at high pH indicates that the protonation of
the heme-binding histidine residue is essential (Fig. 3A). Thus, at high
pH there is a loss of the ability to form a hydrogen bond between the
imidazole ring and the α helix, which is required to restore the HP
form of cyt b559 under illumination. The loss of the ability to form the
light-induced HP form of cyt b559 in histidine-modiﬁed PSII mem-
branes supported this conclusion (Fig. 4, middle column).4.2. Oxygen-dependent conversion of cyt b559 from the IP to the HP form
Removal of molecular oxygen using oxygen trap resulted in the
conversion of the IP to the HP form of cyt b559, while the heme iron
remained in the oxidized state (Eq. (2)).
IP cyt b559ðFe3+Þ→anaerobic HP cyt b559ðFe3+Þ ðpH  independentÞ: ð2Þ
The observation that conversion from the IP to the HP form of cyt
b559 proceeds independently of pH in the medium reveals that the
proton concentration in the polar phase is unlikely to be the limiting
factor for oxygen-dependent conversion from the IP to the HP form of
cyt b559 (Fig. 3B). This proposal is supported by the fact that oxygen-
dependent conversion from the IP to the HP form of cyt b559 was
observed in histidine-modiﬁed PSII membranes (Fig. 4, right column).
Based on these observations one can deduce that oxygen-dependent
conversion from the IP to the HP form of cyt b559 is unlikely to be
dependent on protonation of the histidine residue.
These ﬁndings support the hypothesis that the mechanism behind
the conversion of the IP to the HP form of cyt b559 under illumination
and anaerobic conditions is different. It has been previously proposed
that molecular oxygen attacks hydrogen bonds between the imidaz-
ole group of histidine and the polypeptide backbone and thus
maintains cyt b559 in the LP form under aerobic conditions [28]. The
establishment of highly hydrophobic environment around the heme
group is widely considered as crucial for the formation and
maintenance of the unstable HP form of cyt b559 [18,20]. A recent
study performed on PSII membranes with a sequential depletion of
extrinsic polypeptides and water-splitting manganese complex
proposed that damage of oxygen channels alters the environment
around the heme iron and thus changes redox properties of cyt b559
[29]. Recent crystal structure provided the evidence that the heme of
cyt b559 is covered by the fatty acids of SQDG4, MDGD7 and the
isoprenoid chain of the plastoquinone molecule in the PQ-PQH2
exchange channel II maintaining thus hydrophobic environment
around the heme [14]. In agreement with these proposals it seems
likely that the removal of molecular oxygen changes the microenvi-
ronment around the heme. It is proposed that the absence of
molecular oxygen caused an enhancement in the hydrophobicity
around the heme and restoration of the HP form of cyt b559.
5. Conclusion
The light-induced conversion of cyt b559 from the IP to the HP form
is a photochemical process that involves the interaction of O2•− with
the heme iron. However, conversion of cyt b559 from the IP to the HP
form caused by the removal of molecular oxygen seems to be a
biochemical process that is induced by changes in the microenviron-
ment around the heme of cyt b559. This seems to be the possible
reason behindwhy the heme iron remains in the oxidized state during
oxygen-dependent conversion of the IP to the HP form of cyt b559.
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